Central anticholinergic effects of N-ethyl-2-pyrrolidylmethyl-cyclopentylphenyl glycollate. 1977

Z Szreniawski, and W Kostowski, and J Meszaros, and S Gajewska, and J Faff, and W Bak, and S Rump

The following effects of N-ethyl-2-pyrrolidyl-methyl-cyclopentylphenyl glycollate (PMCG) have been studied: effects on aggressive behaviour in mice and on general behaviour in rats, protective effects against central action of arecoline and nicotine in mice, thermo-regulatory effects in mice, protective action in poisonings with fluostigmine in mice and rats, and effects on bioelectrical activity of the brain in cats. It was stated that PMCG possesses a strong central anticholinergic activity blocking predominantly central muscarinic receptors; PMCG had also strong protective effects in anticholinesterase intoxications. It is suggested that this drug could have antiemotional and antiparkinsonian properties.

UI MeSH Term Description Entries
D008297 Male Males
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D001833 Body Temperature Regulation The processes of heating and cooling that an organism uses to control its temperature. Heat Loss,Thermoregulation,Regulation, Body Temperature,Temperature Regulation, Body,Body Temperature Regulations,Heat Losses,Loss, Heat,Losses, Heat,Regulations, Body Temperature,Temperature Regulations, Body,Thermoregulations
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003517 Cyclopentanes A group of alicyclic hydrocarbons with the general formula R-C5H9. Cyclopentadiene,Cyclopentadienes,Cyclopentene,Cyclopentenes,Cyclopentane
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Z Szreniawski, and W Kostowski, and J Meszaros, and S Gajewska, and J Faff, and W Bak, and S Rump
January 1976, Acta poloniae pharmaceutica,
Z Szreniawski, and W Kostowski, and J Meszaros, and S Gajewska, and J Faff, and W Bak, and S Rump
December 1993, Die Pharmazie,
Z Szreniawski, and W Kostowski, and J Meszaros, and S Gajewska, and J Faff, and W Bak, and S Rump
August 1993, Farmaco (Societa chimica italiana : 1989),
Z Szreniawski, and W Kostowski, and J Meszaros, and S Gajewska, and J Faff, and W Bak, and S Rump
January 1966, Chemotherapy,
Z Szreniawski, and W Kostowski, and J Meszaros, and S Gajewska, and J Faff, and W Bak, and S Rump
December 2007, Acta crystallographica. Section E, Structure reports online,
Z Szreniawski, and W Kostowski, and J Meszaros, and S Gajewska, and J Faff, and W Bak, and S Rump
September 2009, Acta crystallographica. Section E, Structure reports online,
Z Szreniawski, and W Kostowski, and J Meszaros, and S Gajewska, and J Faff, and W Bak, and S Rump
October 1982, Lakartidningen,
Z Szreniawski, and W Kostowski, and J Meszaros, and S Gajewska, and J Faff, and W Bak, and S Rump
January 1970, Acta pharmacologica et toxicologica,
Z Szreniawski, and W Kostowski, and J Meszaros, and S Gajewska, and J Faff, and W Bak, and S Rump
January 1946, Federation proceedings,
Copied contents to your clipboard!